Benjamin T. Marchello, MD

CCOP - Montana Cancer ConsortiumBillings, Montana - 59101 (406-238-6290) Northern Rockies Radiation Oncology CenterBillings, Montana - 59101 (406-238-6290) Hematology-Oncology Centers of the Northern ...Billings, Montana - 59101 (406-238-6290) |
- CLINICAL TRIALS 86
- CONDITIONS104
- INTERVENTIONS138
- SINCE1989

Zoledronic Acid in Treating Patients With Metastatic Breast Cancer Metastatic Prostate Cancer or Multiple Myeloma With Bone Involvement
March 2009 - May 2015

Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
June 2008 - December 2009

Acute Pain Caused by Paclitaxel in Patients With Cancer
February 2009 - April 2011

Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
April 2008 - June 2011

Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
July 2009 - June 2012

Oxaliplatin Leucovorin Calcium and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
June 2010 - February 2013

Adjuvant Doxorubicin Cyclophosphamide and Paclitaxel in Treating Patients With Breast Cancer
November 2003 - June 2012

Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma
May 2010 - April 2011

Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
April 2008 - January 2010

Irinotecan Oxaliplatin and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer
May 2007 - September 2008

Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
January 2010 - January 2012

Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal Junction
August 2009 - November 2010

Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma
July 2009 - February 2012

Zoledronate Vitamin D and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer Lung Cancer or Breast Cancer
July 2006 - March 2013

Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
September 2007 - January 2013

Bevacizumab and Paclitaxel Paclitaxel Albumin-Stabilized Nanoparticle Formulation or Ixabepilone in Treating Patients With Stage IIIC or Stage IV Breast Cancer
October 2008 - October 2010

Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
December 2008 - February 2011

Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
August 2010 - October 2012

Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II Stage III or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma
September 2005 - January 2015

Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
March 2008 - May 2012

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
August 2008 - August 2013

Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
May 2010 - May 2011

Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
March 2005 - June 2015

Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB Recurrent or Persistent Cervical Cancer
April 2009 - December 2011

Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
September 2009 - March 2016

Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced High-Risk Neuroendocrine Tumor
December 2007 - January 2012

Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II Stage III or Stage IV Ovarian Epithelial Cancer Fallopian Tube Cancer or Primary Peritoneal Cancer
August 2009 - January 2016

Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance Multiple Myeloma or Plasmacytoma
June 2002 -

Melphalan Prednisone and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
February 2008 - August 2009

Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
October 2009 - September 2012

Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising PSA After Surgery for Prostate Cancer
February 2008 - December 2017

Paclitaxel Albumin-Stabilized Nanoparticle Formulation Doxorubicin Cyclophosphamide and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
April 2010 - June 2010

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
November 2008 - August 2011

Paclitaxel Cisplatin and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
June 2008 - December 2015

Dinaciclib in Treating Patients With Stage IV Melanoma
July 2009 - May 2010

Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy Paclitaxel and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
March 2009 - March 2013

Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage III or Stage IVA Endometrial Cancer
June 2009 - December 2013

Doxorubicin Cyclophosphamide and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk Lymph Node-Negative Breast Cancer
November 2007 - November 2013

American Ginseng in Treating Patients With Fatigue Caused by Cancer
October 2008 - October 2010

Epratuzumab Cytarabine and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
September 2010 - June 2011

Azacitidine With or Without MS-275 in Treating Patients With Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia or Acute Myeloid Leukemia
August 2006 - February 2008

Collecting and Storing Blood and Bone Marrow Samples From Patients With Myeloma Waldenstrom's Macroglobulinemia Amyloidosis or Monoclonal Gammopathy of Undetermined Significance
November 2003 -

High-Dose or Standard-Dose Radiation Therapy and Chemotherapy in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
November 2007 - January 2014

Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
December 2008 - April 2015

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
October 2007 - September 2012

Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
March 2005 -

Collecting Analyzing and Storing Tissue Samples From Patients With Non-Hodgkin's Lymphoma
February 1989 -

Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy
October 2006 - September 2011

Erlotinib and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
July 2007 - November 2007

Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I Stage II or Stage IIIA Breast Cancer Undergoing Chemotherapy
September 2009 - January 2012

Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
March 1993 -

Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
December 2006 - September 2011

Azacitidine and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
December 2008 - January 2011

Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I Stage II or Stage III Non-Small Cell Lung Cancer
October 2005 - February 2008

Gemcitabine and Cisplatin in Treating Patients With Stage I Non-Small Cell Lung Cancer That Was Removed by Surgery
November 2008 - August 2009

Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
May 2008 - February 2009

Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II Stage IIIA or Stage IIIB Breast Cancer
July 2009 - October 2013

Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone
March 2007 - November 2011

Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
July 2006 - April 2024

Capecitabine Gemcitabine and Radiation Therapy in Treating Patients With Cholangiocarcinoma of the Gallbladder or Bile Duct
December 2008 - December 2010

Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
August 2009 - February 2015

Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers
July 1991 -

Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
May 2009 - July 2010

Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
July 2005 - July 2012

Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
April 1999 -

Bevacizumab Sorafenib and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
September 2007 - May 2012

Erlotinib With or Without Carboplatin and Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
December 2008 - November 2010

Iodine I 131 Tositumomab Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Stage II Stage III or Stage IV Follicular Non-Hodgkin Lymphoma
September 2008 - October 2012

Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
June 2003 - December 2008

Rituximab Cladribine and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
April 2009 -

Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
May 2005 - March 2010

Carboplatin Paclitaxel and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary
October 2009 - November 2010

Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer Fallopian Tube Cancer and/or Primary Peritoneal Cancer
December 2009 - October 2014

Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
June 2007 - January 2010

High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis
January 2004 - July 2014

Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
October 2003 - January 2016

Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Patients Undergoing Surgery for Stage I Stage II or Stage IIIA Breast Cancer
January 2007 - January 2010

Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
July 2009 - August 2011

Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
March 2010 - January 2020

Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer
September 2009 - August 2011

Idarubicin Cytarabine and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
August 2009 - June 2011

Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
July 2010 - July 2013

Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB Stage II or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
June 2007 - July 2015

Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
January 2004 - January 2008

Everolimus Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
March 2009 - September 2009

Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer Fallopian Tube Cancer or Primary Peritoneal Cancer
March 2010 - October 2011
Breast Neoplasms
Colonic Neoplasms
Lung Neoplasms
Brain Neoplasms
Nervous System Neoplasms
Central Nervous System Neoplasms
Lymphoma
Lymphoma, Non-Hodgkin
Adenocarcinoma
Prostatic Neoplasms
Amyloidosis
Multiple Myeloma
Neoplasms, Plasma Cell
Leukemia
Leukemia, Lymphoid
Neoplasms
Neoplasm Metastasis
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Leukemia, Myeloid, Acute
Leukemia, Myeloid
Myelodysplastic Syndromes
Preleukemia
Leukemia, Myelomonocytic, Acute
Leukemia, Myelomonocytic, Chronic
Ovarian Neoplasms
Urinary Bladder Neoplasms
Carcinoma, Renal Cell
Kidney Neoplasms
Carcinoma
Liver Neoplasms
Carcinoma, Hepatocellular
Fatigue
Pancreatic Neoplasms
Head and Neck Neoplasms
Carcinoma, Non-Small-Cell Lung
Esophageal Diseases
Esophageal Neoplasms
Stomach Neoplasms
Bone Neoplasms
Bone Marrow Diseases
Lymphoma, T-Cell
Nausea
Vomiting
Neoplasms, Unknown Primary
Melanoma
Peritoneal Neoplasms
Fallopian Tube Neoplasms
Glioblastoma
Glioma
Mesothelioma
Carcinoma, Small Cell
Astrocytoma
Oligodendroglioma
Infertility
Neurotoxicity Syndromes
Precancerous Conditions
Endometrial Neoplasms
Uterine Cervical Neoplasms
Hodgkin Disease
Myeloproliferative Disorders
Sarcoma
Colorectal Neoplasms
Carcinoma, Transitional Cell
Lymphoma, Large-Cell, Immunoblastic
Neuroendocrine Tumors
Ovarian Failure, Premature
Lymphoma, B-Cell
Lymphoma, Large B-Cell, Diffuse
Hematologic Neoplasms
Cholangiocarcinoma
Peripheral Nervous System Diseases
Demyelinating Diseases
Polyneuropathies
Neurologic Manifestations
Lymphoma, Follicular
Radiation Injuries
Carcinoma in Situ
Carcinoma, Intraductal, Noninfiltrating
Lymphoproliferative Disorders
Anus Neoplasms
Waldenstrom Macroglobulinemia
Carcinoma, Ductal, Breast
Lymphoma, Mantle-Cell
Gallbladder Neoplasms
Carcinoid Tumor
Bile Duct Neoplasms
Ureteral Neoplasms
Gastrointestinal Neoplasms
Carcinoma, Ductal
Burkitt Lymphoma
Duodenal Neoplasms
Ileal Neoplasms
Jejunal Neoplasms
Intestinal Neoplasms
Osteonecrosis
Malignant Carcinoid Syndrome
Urologic Neoplasms
Carcinoma, Neuroendocrine
Monoclonal Gammopathies, Benign
Plasmacytoma
Paraproteinemias
Adenocarcinoma, Bronchiolo-Alveolar
Urethral Neoplasms
Carcinosarcoma
Placebo
Intensity-Modulated Radiation Therapy
Computed Tomography
Melphalan
Immunohistochemistry Staining Method
Laboratory Biomarker Analysis
Liquid Chromatography
Rituximab
Zoledronic Acid
Questionnaire Administration
Filgrastim
Celecoxib
Study Of Socioeconomic And Demographic Variables
Assessment Of Therapy Complications
Aflibercept
Pharmacological Study
Fludeoxyglucose F 18
Paclitaxel
Carboplatin
Bevacizumab
Cisplatin
Docetaxel
Fluorouracil
Leucovorin Calcium
Neoadjuvant Therapy
Therapeutic Conventional Surgery
Dasatinib
Erlotinib Hydrochloride
Gemcitabine Hydrochloride
Gene Expression Analysis
Polymorphism Analysis
Adjuvant Therapy
Cyclophosphamide
Prednisone
Ifosfamide
Radiation Therapy
Lenalidomide
Pemetrexed Disodium
Methotrexate
Methylprednisolone
Temozolomide
Capecitabine
3-Dimensional Conformal Radiation Therapy
Oxaliplatin
Epratuzumab
Cytarabine
Doxorubicin Hydrochloride
Etoposide
Pegaspargase
Vincristine Sulfate
Temsirolimus
Bortezomib
Dexamethasone
Mercaptopurine
Protein Expression Analysis
Polymerase Chain Reaction
Sunitinib Malate
Vitamin D
Vinblastine Sulfate
Bicalutamide
Flutamide
Goserelin
Leuprolide Acetate
Mass Spectrometry
Microarray Analysis
Everolimus
Trastuzumab
Pegfilgrastim
Sorafenib Tosylate
Palonosetron Hydrochloride
Thalidomide
Daunorubicin Hydrochloride
Thioguanine
Peripheral Blood Stem Cell Transplantation
Fluorescence In Situ Hybridization
Rosuvastatin
Conventional Surgery
Systemic Chemotherapy
Azacitidine
Mutation Analysis
Cetuximab
Iodine I 131 Tositumomab
Biologic Sample Preservation Procedure
3'-Deoxy-3'-[18f]Fluorothymidine
Clofarabine
Study Of High Risk Factors
Matrix-Assisted Laser Desorption/Ionization Time Of Flight Mass Spectrometry
Imatinib Mesylate
Calcium Carbonate
Tamoxifen Citrate
Irinotecan Hydrochloride
Mitomycin C
Ixabepilone
Gemtuzumab Ozogamicin
Paclitaxel Albumin-Stabilized Nanoparticle Formulation
Topotecan Hydrochloride
Pravastatin
Dacarbazine
Letrozole
Nucleic Acid Sequencing
Ac Regimen
Vandetanib
Cytogenetic Analysis
Chemotherapy
Duloxetine Hydrochloride
Idarubicin
Seneca Valley Virus-001
Bleomycin Sulfate
Abvd Regimen
Beacopp Regimen
Procarbazine Hydrochloride
Brachytherapy
Calcium Citrate
Calcium Glucarate
Calcium Gluconate
Samarium Sm 153 Lexidronam Pentasodium
Strontium Chloride Sr 89
Vinorelbine Ditartrate
Glutathione
Entinostat
Single Photon Emission Computed Tomography
Pixantrone Dimaleate
Cladribine
Placebo Administration
Recombinant Interferon Alfa-2b
Octreotide Acetate
Dinaciclib
American Ginseng
Tositumomab
Acetyl-L-Carnitine Hydrochloride
Cryopreservation
Chromogenic In Situ Hybridization
Fluorescent Antibody Technique
Sentinel Lymph Node Biopsy
Active Surveillance
Axillary Lymph Node Dissection
Ultrasound Imaging
Antiandrogen Therapy



